Maynard, Massachusetts
United States
23
2025-08-14
The entities that hold a legal rights for patent applications filed by inventor Carven Gregory J.:
Gregory J. Carven from Maynard, US has applied for patents for these inventions. The list has both pending applications and granted patents:
HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOF
#2 | 2025-07-03ISOFORM-SELECTIVE TGFB1 INHIBITORS AND USE THEREOF
#3 | 2025-05-08TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF
#4 | 2024-01-18ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF
#5 | 2023-12-28Tissue factor pathway inhibitor antibodies and uses thereof
#6 | 2023-06-22ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF
#7 | 2022-03-03Isoform-selective TGFB1 inhibitors and use thereof
#8 | 2021-11-04TGFß1 INHIBITORS AND USE THEREOF
#9 | 2021-09-09TGFβ antibodies, methods and uses
#10 | 2021-04-29Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitors
#11 | 2021-04-08Tissue factor pathway inhibitor antibodies and uses thereof
#12 | 2021-02-18Methods for using anti-myostatin antibodies
#13 | 2020-07-23LTBP COMPLEX-SPECIFIC INHIBITORS OF TGF-BETA 1 AND USES THEREOF
#14 | 2020-06-18Tissue factor pathway inhibitor antibodies and uses thereof
#15 | 2020-06-11LRRC33 INHIBITORS AND USE THEREOF
#16 | 2020-03-12Isoform-selective TGFβ1 inhibitors and use thereof
#17 | 2019-09-26TGFBeta Antibodies, Methods and Uses
#18 | 2019-07-11ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF
#19 | 2019-03-07TGFβ1-binding immunoglobulins and use thereof
#20 | 2018-12-06Anti-pro/latent-Myostatin antibodies and uses thereof
#21 | 2018-07-26ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF
#22 | 2017-11-23Anti-pro/latent-myostatin antibodies and uses thereof
#23 | 2017-03-16Tissue factor pathway inhibitor antibodies and uses thereof
1823239 ⎘